Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam + propofol versus dexmedetomidine + propofol versus ketamine + propofol for sedation during lower gastrointestinal endoscopy
PACTR202405727585104Not yet recruiting
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in None and gastrointestinal conditions comparing Midazolam + propofol group, Dexmedetomidine + propofol group and Ketamine + propofol group (3 arms). Primary endpoint: Recovery time. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
midazolampropofoldexmedetomidineketamine
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on PACTR202405727585104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202405727585104.